Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.

IS:ONCSM Turkey Medical Devices
Market Cap
$164.77 Million
TL5.84 Billion TRY
Market Cap Rank
#23557 Global
#332 in Turkey
Share Price
TL245.00
Change (1 day)
+1.66%
52-Week Range
TL76.85 - TL342.00
All Time High
TL342.00
About

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi manufactures and sells chemotherapy drug preparation kits, medical devices, and test kits in Turkey. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system, chemotherapy drugs, cephalosporins, penicillins,… Read more

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2024: 0.126x

Based on the latest financial reports, Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a cash flow conversion efficiency ratio of 0.126x as of September 2024.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL33.37 Million) by net assets (TL263.88 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. - Cash Flow Conversion Efficiency Trend (2020–2023)

This chart illustrates how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)

The table below shows the annual cash flow conversion efficiency of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2023.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-12-31 TL231.70 Million TL-38.10 Million -0.164x -169.94%
2022-12-31 TL224.08 Million TL52.69 Million 0.235x -64.14%
2021-12-31 TL78.80 Million TL51.68 Million 0.656x +156.87%
2020-12-31 TL76.02 Million TL19.41 Million 0.255x --